These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 18598189)

  • 1. Dengue in Vietnamese infants--results of infection-enhancement assays correlate with age-related disease epidemiology, and cellular immune responses correlate with disease severity.
    Chau TN; Quyen NT; Thuy TT; Tuan NM; Hoang DM; Dung NT; Lien le B; Quy NT; Hieu NT; Hieu LT; Hien TT; Hung NT; Farrar J; Simmons CP
    J Infect Dis; 2008 Aug; 198(4):516-24. PubMed ID: 18598189
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Patterns of Cellular Immunity Associated with Experimental Infection with rDEN2Δ30 (Tonga/74) Support Its Suitability as a Human Dengue Virus Challenge Strain.
    Grifoni A; Angelo M; Sidney J; Paul S; Peters B; de Silva AD; Phillips E; Mallal S; Diehl SA; Botten J; Boyson J; Kirkpatrick BD; Whitehead SS; Durbin AP; Sette A; Weiskopf D
    J Virol; 2017 Apr; 91(8):. PubMed ID: 28148797
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Maternal antibody and viral factors in the pathogenesis of dengue virus in infants.
    Simmons CP; Chau TN; Thuy TT; Tuan NM; Hoang DM; Thien NT; Lien le B; Quy NT; Hieu NT; Hien TT; McElnea C; Young P; Whitehead S; Hung NT; Farrar J
    J Infect Dis; 2007 Aug; 196(3):416-24. PubMed ID: 17597456
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Innate Immune Cytokine Profiling and Biomarker Identification for Outcome in Dengue Patients.
    Pradeep SP; Hoovina Venkatesh P; Manchala NR; Vayal Veedu A; Basavaraju RK; Selvasundari L; Ramakrishna M; Chandrakiran Y; Krishnamurthy V; Holigi S; Thomas T; Ross CR; Dias M; Satchidanandam V
    Front Immunol; 2021; 12():677874. PubMed ID: 34335578
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunodominant Dengue Virus-Specific CD8+ T Cell Responses Are Associated with a Memory PD-1+ Phenotype.
    de Alwis R; Bangs DJ; Angelo MA; Cerpas C; Fernando A; Sidney J; Peters B; Gresh L; Balmaseda A; de Silva AD; Harris E; Sette A; Weiskopf D
    J Virol; 2016 May; 90(9):4771-4779. PubMed ID: 26912627
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Kinetics of CD4
    Manh DH; Weiss LN; Thuong NV; Mizukami S; Dumre SP; Luong QC; Thanh LC; Thang CM; Huu PT; Phuc LH; Nhung CTH; Mai NT; Truong NQ; Ngu VTT; Quoc DK; Ha TTN; Ton T; An TV; Halhouli O; Quynh LN; Kamel MG; Karbwang J; Huong VTQ; Huy NT; Hirayama K
    Front Immunol; 2020; 11():1980. PubMed ID: 33072068
    [No Abstract]   [Full Text] [Related]  

  • 7. Strong HLA class I--restricted T cell responses in dengue hemorrhagic fever: a double-edged sword?
    Loke H; Bethell DB; Phuong CX; Dung M; Schneider J; White NJ; Day NP; Farrar J; Hill AV
    J Infect Dis; 2001 Dec; 184(11):1369-73. PubMed ID: 11709777
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activated peripheral lymphocytes with increased expression of cell adhesion molecules and cytotoxic markers are associated with dengue fever disease.
    Azeredo EL; Zagne SM; Alvarenga AR; Nogueira RM; Kubelka CF; de Oliveira-Pinto LM
    Mem Inst Oswaldo Cruz; 2006 Jun; 101(4):437-49. PubMed ID: 16951817
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human CD4
    Angelo MA; Grifoni A; O'Rourke PH; Sidney J; Paul S; Peters B; de Silva AD; Phillips E; Mallal S; Diehl SA; Kirkpatrick BD; Whitehead SS; Durbin AP; Sette A; Weiskopf D
    J Virol; 2017 Mar; 91(5):. PubMed ID: 27974563
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combination of Modified NS1 and NS3 as a Novel Vaccine Strategy against Dengue Virus Infection.
    Kao YS; Yu CY; Huang HJ; Tien SM; Wang WY; Yang M; Anderson R; Yeh TM; Lin YS; Wan SW
    J Immunol; 2019 Oct; 203(7):1909-1917. PubMed ID: 31451673
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dynamics of cellular immune responses in the acute phase of dengue virus infection.
    Yoshida T; Omatsu T; Saito A; Katakai Y; Iwasaki Y; Kurosawa T; Hamano M; Higashino A; Nakamura S; Takasaki T; Yasutomi Y; Kurane I; Akari H
    Arch Virol; 2013 Jun; 158(6):1209-20. PubMed ID: 23381396
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cross-Reactivity and Anti-viral Function of Dengue Capsid and NS3-Specific Memory T Cells Toward Zika Virus.
    Lim MQ; Kumaran EAP; Tan HC; Lye DC; Leo YS; Ooi EE; MacAry PA; Bertoletti A; Rivino L
    Front Immunol; 2018; 9():2225. PubMed ID: 30327651
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early T-cell responses to dengue virus epitopes in Vietnamese adults with secondary dengue virus infections.
    Simmons CP; Dong T; Chau NV; Dung NT; Chau TN; Thao le TT; Dung NT; Hien TT; Rowland-Jones S; Farrar J
    J Virol; 2005 May; 79(9):5665-75. PubMed ID: 15827181
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dengue vaccine-induced CD8+ T cell immunity confers protection in the context of enhancing, interfering maternal antibodies.
    Lam JH; Chua YL; Lee PX; Martínez Gómez JM; Ooi EE; Alonso S
    JCI Insight; 2017 Dec; 2(24):. PubMed ID: 29263304
    [TBL] [Abstract][Full Text] [Related]  

  • 15. T-cells producing multiple combinations of IFNγ, TNF and IL10 are associated with mild forms of dengue infection.
    Gonçalves Pereira MH; Figueiredo MM; Queiroz CP; Magalhães TVB; Mafra A; Diniz LMO; da Costa ÚL; Gollob KJ; Antonelli LRDV; Santiago HDC
    Immunology; 2020 May; 160(1):90-102. PubMed ID: 32128816
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD4
    Rivino L; Lim MQ
    Immunology; 2017 Feb; 150(2):146-154. PubMed ID: 27763656
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dominant recognition by human CD8+ cytotoxic T lymphocytes of dengue virus nonstructural proteins NS3 and NS1.2a.
    Mathew A; Kurane I; Rothman AL; Zeng LL; Brinton MA; Ennis FA
    J Clin Invest; 1996 Oct; 98(7):1684-91. PubMed ID: 8833919
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human immune responses to dengue viruses.
    Kurane I; Innis BL; Nimmannitya S; Nisalak A; Rothman AL; Livingston PG; Janus J; Ennis FA
    Southeast Asian J Trop Med Public Health; 1990 Dec; 21(4):658-62. PubMed ID: 1983049
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dengue fever virus and Japanese encephalitis virus synthetic peptides, with motifs to fit HLA class I haplotypes prevalent in human populations in endemic regions, can be used for application to skin Langerhans cells to prime antiviral CD8+ cytotoxic T cells (CTLs)--a novel approach to the protection of humans.
    Becker Y
    Virus Genes; 1994 Sep; 9(1):33-45. PubMed ID: 7871759
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predominance of HLA-restricted cytotoxic T-lymphocyte responses to serotype-cross-reactive epitopes on nonstructural proteins following natural secondary dengue virus infection.
    Mathew A; Kurane I; Green S; Stephens HA; Vaughn DW; Kalayanarooj S; Suntayakorn S; Chandanayingyong D; Ennis FA; Rothman AL
    J Virol; 1998 May; 72(5):3999-4004. PubMed ID: 9557687
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.